Acorda Therapeutics

Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:15 am
Arena Pharmaceuticals
Vivus
Orexigen
Novo Nordisk
Amylin
Eli Lilly
Biogen Idec
Acorda Therapeutics
Dendreon
MannKind
Biotech's Best Quotes Go Straight to the Heart of 2009 Industry Trends
BNET Pharma
Tue, 01/5/10 - 12:12 pm
biotech
Acorda Therapeutics
Kalos
Arena Pharmaceuticals
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:56 am
FDA
Dendreon
Arena Pharmaceuticals
Chelsea Therapeutics
Cephalon
Biodel
Auxilium
Novartis
Novo Nordisk
Shire
Vivus
MannKind
Acorda Therapeutics
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thu, 10/22/09 - 09:14 am
Acorda Therapeutics
FDA
MS
multiple sclerosis
Fampridine-SR
FDA Panel Votes 'Yes' on Acorda Drug Efficacy
TheStreet.com
Wed, 10/14/09 - 08:15 pm
Acorda Therapeutics
FDA
Biogen Idec
Amaya
A Mixed Bag for Traders and Investors in Healthcare
Seeking Alpha
Mon, 10/12/09 - 06:03 pm
Acorda Therapeutics
Spectrum Pharmaceuticals
Cytori
Cryo-Cell
Novavax
Stage Set for Acorda Bounce?
Seeking Alpha
Mon, 10/12/09 - 11:18 am
Acorda Therapeutics
Biogen Idec
Avanir, Acorda move on MS drug updates
Market Watch
Sat, 10/10/09 - 12:38 pm
Avanir
Acorda Therapeutics
MS
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Fri, 10/9/09 - 09:30 am
Acorda Therapeutics
MS
multiple sclerosis
Fampridine-SR
Acorda Therapeutics cites additional positive safety data on multiple sclerosis drug
Yahoo/AP
Tue, 09/15/09 - 07:47 pm
Acorda Therapeutics
multiple sclerosis
MS
Fampridine-SR
Biogen Maintains Facet Offer
Yahoo/Zacks.com
Thu, 09/10/09 - 08:52 am
Biogen Idec
Facet Biotech
M&A
Acorda Therapeutics
Bristol-Myers Squibb
Acorda confirms FDA panel review date for MS drug
Yahoo/AP
Tue, 08/25/09 - 12:22 pm
Acorda Therapeutics
MS
FDA
multiple sclerosis
Fampridine-SR
Biogen Profit Falls on Cost of Acorda Partnership
Bloomberg
Thu, 07/16/09 - 08:55 am
Biogen Idec
earnings
Acorda Therapeutics
Dealmaking Sweeps the Biotech Sector
Seeking Alpha
Sun, 07/5/09 - 06:06 pm
JNJ
Elan
Cell Genesys
CombinatoRx
Acorda Therapeutics
BioSante
Biogen Idec
Geron
Roche
Mylan
Wyeth
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Bloomberg
Wed, 07/1/09 - 09:05 am
Biogen Idec
Acorda Therapeutics
Fampridine-SR
MS
We're Positive on Acorda
Yahoo/Zacks.com
Tue, 06/23/09 - 08:36 am
Acorda Therapeutics
Fampridine-SR
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Seeking Alpha
Wed, 05/27/09 - 07:41 am
Gilead Sciences
Amgen
Human Genome Sciences
Acorda Therapeutics
Biomarin
Amag Pharmaceuticals
Biogen Idec
Genzyme
Cougar Biotechnology
JNJ
OSI Pharmaceuticals
Cephalon
Allergan
Celgene
Myriad
Sequenom
Auxilium
Acorda Pops On Good News
Yahoo/Zacks.com
Wed, 05/6/09 - 06:10 pm
Acorda Therapeutics
Biogen Idec
Pfizer
Sanofi
Why I Doubt the FDA Will Approve Acorda's Fampridine
Seeking Alpha
Fri, 04/24/09 - 06:15 am
Acorda Therapeutics
FDA
Fampiridine
antihypertensives
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thu, 04/23/09 - 10:05 am
FDA
drug trials
Acorda Therapeutics
GTx
Alkermes

Pages